Home > Balance Sheet > CORONA REMEDIES

CORONA REMEDIES
Sundry Debtors

    Back to Balance Sheet
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Sundry Debtors History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Sundry Debtors ₹146 Cr₹118 Cr₹100 Cr₹87 Cr

What is the latest Sundry Debtors ratio of CORONA REMEDIES ?

The latest Sundry Debtors ratio of CORONA REMEDIES is ₹146 Cr based on Mar2026 Consolidated results.
Year Sundry Debtors
Mar2026₹146 Cr
Mar2025₹118 Cr
Mar2024₹100 Cr
Mar2023₹87 Cr

How is Sundry Debtors of CORONA REMEDIES Trending?

Years Sundry Debtors % Change
Mar2026 ₹146 Cr
23.05
Mar2025 ₹118 Cr
18.37
Mar2024 ₹100 Cr
14.88
Mar2023 ₹87 Cr -

Compare Sundry Debtors of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹12,574.8 Cr 2.7% -5.9% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,204.0 Cr -1% -5.5% 5.7% Stock Analytics
DIVIS LABORATORIES ₹238,497.0 Cr -2.6% -3.9% 38.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹170,481.0 Cr -1.7% -10.2% 30.5% Stock Analytics
CIPLA ₹108,012.0 Cr 0.9% -3.2% -15.2% Stock Analytics
DR REDDYS LABORATORIES ₹102,207.0 Cr -0.6% 1% -0.1% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

2.7%

-5.9%

NA
SENSEX

-1.6%

-2.3%

-11.5%


You may also like the below Video Courses